$AKT remains a top project for me.
I have to say, @gregosuri is one of the most dedicated and ethical founders in the space. Never witnessed a single red flag over the years. Happy to have been part of the community since day 1.
With nonstop innovation Akash will survive and thrive!
@_ItalianDesign@P0eMPieDinges Gaat iets goed mis bij de controle op wie ze binnen laten… bizar eigenlijk dat dit soort shit hier gewoon binnen kan komen.
@theArmandB When i knew what it was all about, knew i had to buy it.
Two cycles ago I almost bought Injective at $1. Watched it run to $20.
Next cycle, same story at $1. Chose Solana at $12 instead. Then watched $INJ run to $50.
It escaped me twice. There won't be a third time.
GN 🥷🏻
While most are watching price of $INJ, the real story is happening on-chain.
@injective just printed a new ATH in active addresses, averaging 90K+ weekly.
This isn't a one-off spike.
It's been a steady climb for months.
Price may be waking up sooner than you think, but the network has been telling the story all along.
Adoption first.
Price follows.
Sleep well, ninjas 🥷
This week we just finished the largest community buyback event yet, worth over $315,000 in onchain revenue.
Next week we will use the funds to burn $INJ forever.
@TedPillows@anargorj Define altseason.. because a handful of alts wil definitely have their “season”. Times of throwing a dart on top 100 are over. You need to which ones to hold.
@Coinslinger88@Ali_the_Curios Past cycles without bme, went to 4/6 dollars? Next year it will most likely do the same. Did you mean this year its not possible? Because that would make sense.. next year this thing will pop for sure.